Kezar Life Sciences (KZR) Financials

$7.29

$0.00 (0.00%)

As on 11-May-2026 09:30EDT

Market cap

$54 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	7.00	--	--
Cost of Revenue	0.40	0.90	1.04	1.07	1.02	1.51
Gross Profit	-0.40	-0.90	-1.04	7.00	-1.02	-1.51
Operating Expenses	41.83	51.37	90.61	118.42	71.16	53.15
Operating Profit (EBIT)	-42.01	-52.27	-90.61	-111.42	-71.16	-54.66
Other Income	--	--	--	--	--	--
Profit before Tax	-45.23	-56.03	-83.74	-101.87	-68.24	-54.63
Provision for Tax	--	--	--	0.90	-2.92	-1.35
Profit after Tax (Net Income)	-45.23	-56.03	-83.74	-101.87	-65.32	-54.63
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-68.24	-54.63

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	65.24	70.07	116.92	187.57	269.87	196.88
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	7.44	15.92	18.70	12.85
Current Liabilities	2.76	6.57	20.33	17.74	11.00	8.21
Total Liabilities	70.76	76.65	144.68	221.24	299.57	217.93

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.44	0.92	7.19	14.29	13.85	6.28
Current Assets	67.56	75.73	137.49	206.95	285.72	211.65
Total Assets	135.56	76.65	144.68	221.24	299.57	217.93
Total Debt*	1.35	2.33	16.18	18.93	21.26	14.04
Net Current Assets	--	69.16	117.16	189.21	274.73	203.44

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-51.78	-74.21	-81.65	-58.85	-42.44
Cash Flow from Investing Activities	--	92.46	80.43	76.05	-91.39	-28.44
Cash from Financing Activities	--	-10.59	0.10	0.64	127.86	112.59
Net Cash Inflow / Outflow	--	--	--	--	-22.38	41.70

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-6.18	-7.66	-11.47	-1.40	-0.90	-0.98
Cash EPS ($)	--	-7.54	-11.33	-1.39	-0.89	-0.95
Adjusted Book Value ($)	--	9.58	16.02	2.58	3.74	3.52
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-7.08	-10.17	-1.12	-0.81	-0.76
Free Cash Flow per Share ($)	--	-7.08	-10.17	-1.15	-0.84	-0.76

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-54.53	-49.31	-40.94	-26.02	-30.57
ROE (%)	-61.04	-59.93	-55.00	-44.54	-27.99	-32.34
ROA (%)	-32.57	-50.63	-45.77	-39.12	-25.24	-29.55
EBIT Margin (%)	--	--	--	-1,433.14	--	--
Net Margin (%)	--	--	--	-1,455.29	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	-1.00	--	--	--
EBIT Growth (%)	57.95	36.37	18.12	-40.97	-30.64	-26.82
Net Profit Growth (%)	42.48	33.08	17.80	-55.96	-19.56	-40.11
EPS Growth (%)	-10.15	0.33	-7.19	-0.55	0.07	-0.25
Book Value Growth (%)	-37.03	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.82	-0.59	-0.68	-7.79	-17.13
Price / Book Value	0.77	0.66	0.42	0.37	1.88	4.75
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.06	0.46	0.83	1.14	-3.61	-14.00
Close Price ($)	7.42	6.29	6.72	9.50	70.40	167.20
High Price ($)	7.55	6.93	11.35	74.40	185.50	172.80
Low Price ($)	3.53	3.53	5.20	6.75	43.05	46.10
Market Cap ($ Cr)	53.86	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.14	0.10	0.08	0.07
Short term debt to equity ratio	0.02	0.03	0.07	0.02	0.01	0.01
Current Ratio	24.46	11.52	6.76	11.66	25.98	25.77
Quick Ratio	24.46	--	--	--	--	25.47
Interest Coverage	-43.22	-38.15	-51.56	-64.72	-60.05	-342.58

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	32.73	--	--
Asset Turnover	--	--	--	0.03	--	--
Receivable days	--	--	--	119.54	--	--
Inventory Days	--	--	--	--	892.60	540.26
Payable days	--	846.55	2,090.00	1,838.24	804.59	530.46
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.